CN104474256B - A kind of oral solution for treating pulmonary infection of AIDS - Google Patents
A kind of oral solution for treating pulmonary infection of AIDS Download PDFInfo
- Publication number
- CN104474256B CN104474256B CN201410769091.5A CN201410769091A CN104474256B CN 104474256 B CN104474256 B CN 104474256B CN 201410769091 A CN201410769091 A CN 201410769091A CN 104474256 B CN104474256 B CN 104474256B
- Authority
- CN
- China
- Prior art keywords
- parts
- aids
- radix
- oral solution
- pulmonary infection
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 208000015181 infectious disease Diseases 0.000 title claims abstract description 28
- 230000002685 pulmonary effect Effects 0.000 title claims abstract description 28
- 208000030507 AIDS Diseases 0.000 title claims abstract description 25
- 229940100688 oral solution Drugs 0.000 title claims description 19
- 241000935235 Fritillaria meleagris Species 0.000 claims abstract description 12
- 239000009636 Huang Qi Substances 0.000 claims abstract description 12
- 241001522129 Pinellia Species 0.000 claims abstract description 12
- 244000197580 Poria cocos Species 0.000 claims abstract description 12
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 12
- 240000006079 Schisandra chinensis Species 0.000 claims abstract description 10
- 235000008422 Schisandra chinensis Nutrition 0.000 claims abstract description 10
- 239000002994 raw material Substances 0.000 claims abstract description 6
- 239000000463 material Substances 0.000 claims description 5
- 238000001914 filtration Methods 0.000 claims description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- 230000000857 drug effect Effects 0.000 claims 2
- 235000019640 taste Nutrition 0.000 claims 2
- 206010011224 Cough Diseases 0.000 abstract description 16
- 230000000694 effects Effects 0.000 abstract description 13
- 210000004072 lung Anatomy 0.000 abstract description 11
- 208000024891 symptom Diseases 0.000 abstract description 6
- 206010062717 Increased upper airway secretion Diseases 0.000 abstract description 5
- 206010036790 Productive cough Diseases 0.000 abstract description 5
- 208000026435 phlegm Diseases 0.000 abstract description 5
- 230000003110 anti-inflammatory effect Effects 0.000 abstract description 4
- 208000024794 sputum Diseases 0.000 abstract description 3
- 210000003802 sputum Anatomy 0.000 abstract description 3
- 206010028748 Nasal obstruction Diseases 0.000 abstract description 2
- 230000002924 anti-infective effect Effects 0.000 abstract description 2
- 238000005728 strengthening Methods 0.000 abstract description 2
- 230000001502 supplementing effect Effects 0.000 abstract description 2
- 235000013717 Houttuynia Nutrition 0.000 abstract 1
- 240000000691 Houttuynia cordata Species 0.000 abstract 1
- 206010025482 malaise Diseases 0.000 abstract 1
- 230000001717 pathogenic effect Effects 0.000 abstract 1
- 230000035790 physiological processes and functions Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 description 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 9
- 201000010099 disease Diseases 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 231100000331 toxic Toxicity 0.000 description 5
- 230000002588 toxic effect Effects 0.000 description 5
- 241000219000 Populus Species 0.000 description 4
- 230000007812 deficiency Effects 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 3
- 229920001353 Dextrin Polymers 0.000 description 3
- 239000004375 Dextrin Substances 0.000 description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
- 229930195725 Mannitol Natural products 0.000 description 3
- 206010037660 Pyrexia Diseases 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- 235000021355 Stearic acid Nutrition 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000003115 biocidal effect Effects 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 235000019425 dextrin Nutrition 0.000 description 3
- 235000019441 ethanol Nutrition 0.000 description 3
- 239000008101 lactose Substances 0.000 description 3
- 239000000594 mannitol Substances 0.000 description 3
- 235000010355 mannitol Nutrition 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 3
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 3
- 239000008194 pharmaceutical composition Substances 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 239000008117 stearic acid Substances 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 206010008469 Chest discomfort Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 230000004596 appetite loss Effects 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 208000017574 dry cough Diseases 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 208000019017 loss of appetite Diseases 0.000 description 2
- 235000021266 loss of appetite Nutrition 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000005195 poor health Effects 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 208000031886 HIV Infections Diseases 0.000 description 1
- 208000037357 HIV infectious disease Diseases 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010037549 Purpura Diseases 0.000 description 1
- 241001672981 Purpura Species 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000001147 anti-toxic effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000005321 cobalt glass Substances 0.000 description 1
- 230000001010 compromised effect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 208000013219 diaphoresis Diseases 0.000 description 1
- 206010013023 diphtheria Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 208000033519 human immunodeficiency virus infectious disease Diseases 0.000 description 1
- 230000000642 iatrogenic effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 210000000867 larynx Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 208000023504 respiratory system disease Diseases 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/19—Acanthaceae (Acanthus family)
- A61K36/195—Strobilanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/233—Bupleurum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
- A61K36/315—Isatis, e.g. Dyer's woad
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/79—Schisandraceae (Schisandra family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/85—Verbenaceae (Verbena family)
- A61K36/855—Clerodendrum, e.g. glorybower
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
- A61K36/8888—Pinellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8966—Fritillaria, e.g. checker lily or mission bells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8968—Ophiopogon (Lilyturf)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a kind of oral solutions for treating pulmonary infection of AIDS, are made of following raw materials in parts by weight：5-15 parts of folium isatidis, 10-20 parts of Poria cocos, Radix Ophiopogonis 5-15 part, 15-25 parts of pinellia, 10-20 parts of tendril-leaved fritillary bulb, 10-20 parts of Schisandra chinensis, 5-15 parts of radix bupleuri, 5-15 parts of Radix Astragali, 10-20 parts of Fructus Forsythiae, 5-15 parts of cordate houttuynia.The present invention has clearing heat and detoxicating, preventing phlegm from forming and stopping coughing, eliminating evil outgoing, supplementing qi and nourishing yin, and strengthening vital QI to eliminate pathogenic factors etc. is anti-inflammatory, anti-infectious effect.To enable AIDS patient to restore the normal physiological function of human lung as early as possible.Through clinical application in pulmonary infection of AIDS patient, the substantially reduced cough of energy is coughed up and spits frothy sputum, uncomfortable in chest, out of breath, generates heat, nasal obstruction, and throat, which is itched, waits malaise symptoms.
Description
【Technical field】
The invention belongs to field of medicaments, especially belong to it is a kind of using traditional Chinese medicine at treatment pulmonary infection of AIDS mouth
Take liquid.
【Technical background】
AIDS is a kind of disease of the compromised immune caused by virus infects, and is that a kind of harmfulness greatly infects
Disease is caused by aids infection viral (inhibition of HIV).HIV is a kind of virus that can attack human immune system, it exempts from human body
Most important T lymphocytes make human body lose immune function as primary challenge target, the considerable damage cell in epidemic disease system.
Therefore, human body is easy to infect various diseases, at present still without radical cure measure.
AIDS patient's pulmonary infection occupies larger proportion in respiratory disease or infectious diseases.Due to current
The probability of the limitation of medical condition, the infection of iatrogenic and secondary pulmonary is on the rise.Although antibiotic and other anti-in recent years
The application of microbial medicine can play a role the control of the state of an illness, but with pathogenic microorganism genetic mutation speed
Quickening and the appearance of drug resistance mattress (such as superbacteria) and the reduction of AIDS patient's drug sensitivity, AIDS patient is because of lung
Portion infects overall incidence and the death rate has no and is substantially reduced, and the long-time service of antibiotics, has more apparent
Toxic side effect.There is natural Chinese herbal medicines certain advantage, the present invention to use in terms for the treatment of pulmonary infection of AIDS disease
Traditional Chinese medicine at treatment pulmonary infection of AIDS oral solution, have effects that dispelling wind and heat, removing toxicity for detumescence, diagnosis and treatment based on an overall analysis of the illness and the patient's condition,
Tonification and purgation in combination, treating both manifestation and root cause of disease, and in clinical trial in treating pulmonary infection of AIDS case, obtaining significant treatment effect
Fruit, safe without toxic side effect.
【Invention content】
The purpose of the present invention is to provide a kind of oral solution that can effectively treat pulmonary infection of AIDS, institute of the present invention
The oral solution of the treatment pulmonary infection of AIDS of offer, has clearing heat and detoxicating, preventing phlegm from forming and stopping coughing, eliminating evil is outgoing, supplementing qi and nourishing yin, righting
Eliminating evil etc. is anti-inflammatory, anti-infectious effect, can preferably treat pulmonary infection of AIDS, have no toxic side effect, securely and reliably.
Technical scheme is as follows：
A kind of oral solution for treating pulmonary infection of AIDS, it is characterised in that：The effective component of described pharmaceutical composition by
The raw material of following parts by weight is prepared：Folium isatidis, Poria cocos, Radix Ophiopogonis, pinellia, tendril-leaved fritillary bulb, Schisandra chinensis, radix bupleuri, Radix Astragali.
Further, it is preferable to which the effective component of described pharmaceutical composition is prepared by the raw material of following parts by weight：Smalt
5-15 parts of leaf, 10-20 parts of Poria cocos, Radix Ophiopogonis 5-15 part, 15-25 parts of pinellia, 10-20 parts of tendril-leaved fritillary bulb, 10-20 parts of Schisandra chinensis, radix bupleuri
5-15 parts, 5-15 parts of Radix Astragali.
Further, preferably the effective component of described pharmaceutical composition is prepared by the raw material of following parts by weight：Greatly
10 parts of leafiness, 15 parts of Poria cocos, 10 parts of Radix Ophiopogonis, 20 parts of pinellia, 15 parts of tendril-leaved fritillary bulb, 15 parts of Schisandra chinensis, 10 parts of radix bupleuri, 10 parts of Radix Astragali.
Folium isatidis, warm-natured, acrid-sweet flavor.The diseases such as heat toxin macular eruption, erysipelas, abscess of throat, aphthae, sore and toxic.
Poria cocos, it is sweet in flavor, light, mild-natured, it can eliminating dampness and diuresis；Strengthening the spleen and stomach；Antitoxic heart-soothing and sedative.
Radix Ophiopogonis, nourishing Yin and promoting production of body fluid, moistening lung clears away heart-fire are used for dryness of the lung dry cough, and tuberculosis cough, injury thirst, vexed insomnia, interior heat disappears
Yearningly, dry constipation of intestines, pharyngeal diphtheria.
Pinellia, returns spleen, stomach, lung channel have preventing or arresting vomiting and stomach, eliminating dampness and eliminating phlegm, the effect to relieve the pain of calming the nerves.
Tendril-leaved fritillary bulb, clearing heat and moistening lung, preventing phlegm from forming and stopping coughing are used for lung-heat type cough, and dry cough lacks phlegm, and deficiency of yin and overstrain cough coughs up sputum streaked with blood.Function is controlled
Cough due to consumptive disease, spitting of blood of spitting, ambition Yu Jie, consumptive lung disease, lung carbuncle, larynx numbness, acute mastitis.
Schisandra chinensis, it is sweet in flavor, sour, it is warm-natured.Energy nourishing generate fluid, kidney tonifying nourishing heart restrain astringent method.Hinder for deficiency of vital energy Tianjin, body is tired more
Sweat, palpitaition of losing heart；Breathing with cough caused by insufficiency of lung-QI,deficiency of lung-QI or deficiency of both the lung and kidney, or breath with cough with the passing of time, lung qi consumption wound.
Radix bupleuri, it is bitter, it is slightly cold.Return liver, gallbladder channel.It is soothing the liver in inducing diaphoresis, rising Yang.For cold, fever, fevers and chills alternate, chest side of body
Distending pain.
Radix Astragali, sweet in flavor, slightly warm in nature.It can invigorate the spleen and benefit qi, tonifying lung consolidates table, inducing diuresis to remove edema.
The present invention is had the following advantages compared with prior art using above technical scheme：Formula is simple, assimilation effect
It is good, it is at low cost, significant in efficacy, safe.This formula is dialectical to put to good use, it then follows theory of traditional Chinese medical science significant effect has no toxic side effect.
The following further describes the technical solution of the present invention With reference to embodiment.
【Specific implementation mode】
The following examples can help those skilled in the art that the present invention is more completely understood.But it cannot be with any
Mode limits the present invention, the number in the embodiment of the present invention can be selected as according to the actual needs gram or kilogram.
Embodiment 1
A kind of oral solution for treating pulmonary infection of AIDS is made of (every part of 1g) following components according to weight classification：Greatly
5 parts of leafiness, 10 parts of Poria cocos, 5 parts of Radix Ophiopogonis, 15 parts of pinellia, 10 parts of tendril-leaved fritillary bulb, 10 parts of Schisandra chinensis, 5 parts of radix bupleuri, 5 parts of Radix Astragali.
After above weight classification composition, adds 3-4 times of water, warm fire to decoct -2 hours 1.5 hours by total weight, decoct two
Collecting decoction after secondary, filtering are concentrated into the paste that relative density is 1.20-1.25, then are dried, crushed into carefully at 80 degree or less
Auxiliary material (starch paddle 1%, dextrin 1%, lactose 0.5%, ethyl alcohol 0.5%, stearic acid 0.2%, mannitol 0.1%) is added in powder, mixes
It is even, oral solution is made.
Embodiment 2
A kind of oral solution for treating pulmonary infection of AIDS is made of (every part of 1g) following components according to weight classification：Greatly
10 parts of leafiness, 15 parts of Poria cocos, 10 parts of Radix Ophiopogonis, 20 parts of pinellia, 15 parts of tendril-leaved fritillary bulb, 15 parts of Schisandra chinensis, 10 parts of radix bupleuri, 10 parts of Radix Astragali.
After above weight classification composition, adds 3-4 times of water, warm fire to decoct -2 hours 1.5 hours by total weight, decoct two
Collecting decoction after secondary, filtering are concentrated into the paste that relative density is 1.20-1.25, then are dried, crushed into carefully at 80 degree or less
Auxiliary material (starch paddle 1%, dextrin 1%, lactose 0.5%, ethyl alcohol 0.5%, stearic acid 0.2%, mannitol 0.1%) is added in powder, mixes
It is even, oral solution is made.
Embodiment 3
A kind of oral solution for treating pulmonary infection of AIDS is made of (every part of 1g) following components according to weight classification：Greatly
15 parts of leafiness, 20 parts of Poria cocos, 15 parts of Radix Ophiopogonis, 25 parts of pinellia, 20 parts of tendril-leaved fritillary bulb, 20 parts of Schisandra chinensis, 15 parts of radix bupleuri, 15 parts of Radix Astragali.
After above weight classification composition, adds 3-4 times of water, warm fire to decoct -2 hours 1.5 hours by total weight, decoct two
Collecting decoction after secondary, filtering are concentrated into the paste that relative density is 1.20-1.25, then are dried, crushed into carefully at 80 degree or less
Auxiliary material (starch paddle 1%, dextrin 1%, lactose 0.5%, ethyl alcohol 0.5%, stearic acid 0.2%, mannitol 0.1%) is added in powder, mixes
It is even, oral solution is made.
Model case：
1, Yang, female, 28 years old.Company office worker.Primary dcreening operation HIV is positive when fash occurring within 2007, true by experiment
It examines as HIV infection.Poplar weight is begun to decline, and loss of appetite, indigestion, spirit is poor, often cough, expectoration, chest tightness pain,
It is pulmonary infection to go to hospital to check.The a large amount of antibiotic of doctor's open carries out anti-inflammatory treatment, just starts have an effect, but not more
Prolonged illness feelings start to recur again, and poplar is tormented agonizing.Take the medicine of (embodiment 1) of the invention in March, 2012 upon somebody's introduction
Object, after continuously taking 15 days, poplar pulmonary infection symptom disappears, and after continuously taking 30 days, pulmonary infection symptom thoroughly disappears, and
It thoroughly cures, follow-up is so far without recurrence.
2, rely so-and-so, man, 41 years old, Bose City people.Rely certain to be begun in January, 2009 and feel in poor health, catches a cold often
Fever, changeable, also worse and worse, skin begins with erythema appearance to passive protective physical fitness, and HIV is diagnosed as to hospital's blood test
(positive) is AIDS patient.Doctor had outputed the drug of some enhancing passive protective physical fitness to Huang at that time, but relied certain lung
Start to infect, coughs up often and spit frothy sputum, it is uncomfortable in chest, it is out of breath, it generates heat, nasal obstruction, throat is itched, and it is (real to take the present invention after being introduced
Apply example 2) drug, after continuously taking 15 days, rely certain pulmonary infection symptom disappear, after continuously taking 30 days, pulmonary infection symptom
It thoroughly disappears, and thoroughly cures, follow-up is so far without recurrence.
3, Zhang, female, 38 years old, Guigang people from Guiping County.Zhang's in poor health, body resistance since 2 months 2004
Worse and worse, and skin begins with purpura to power, and in August, 2004 is checked to hospital is diagnosed as HIV (positive), is AIDS sufferer
Person.Zhang's weight is begun to decline, and loss of appetite, indigestion, spirit is poor, often cough, expectoration, and chest tightness pain goes to hospital to examine
It looks into as pulmonary infection.The a large amount of antibiotic of doctor's open carries out anti-inflammatory treatment, just starts have an effect, but soon the state of an illness is again
Start to recur, poplar is tormented agonizing.Zhang household seeks medical advice and medicine everywhere, all has no result.The present invention is taken after being introduced
The drug of (embodiment 3) after continuously taking 15 days, relies certain pulmonary infection symptom to disappear, after continuously taking 30 days, pulmonary infection disease
Shape thoroughly disappears, and thoroughly cures, and follow-up is so far without recurrence.
Although above the present invention is described in detail with a general description of the specific embodiments,
On the basis of the present invention, it can be made some modifications or improvements, this will be apparent to those skilled in the art.Cause
This, these modifications or improvements, belong to the scope of protection of present invention without departing from theon the basis of the spirit of the present invention.
Claims (3)
1. a kind of oral solution for treating pulmonary infection of AIDS, which is characterized in that the effective component of the oral solution is by following former
Material is prepared：5-10 parts of folium isatidis, 10-20 parts of Poria cocos, Radix Ophiopogonis 5-15 part, 15-25 parts of pinellia, 10-20 parts of tendril-leaved fritillary bulb, the five tastes
10-20 parts sub-, 5-15 parts of radix bupleuri, 5-15 parts of Radix Astragali；Folium isatidis, Poria cocos, Radix Ophiopogonis, pinellia, tendril-leaved fritillary bulb, the five tastes are taken by weight ratio
Son, radix bupleuri, Radix Astragali add 3-4 times of water, warm fire to decoct -2 hours 1.5 hours by total weight, collecting decoction after decocting twice, filtering,
Auxiliary material is added, oral solution is made.
2. as described in claim 1 treatment pulmonary infection of AIDS oral solution, which is characterized in that the drug effect of the oral solution at
Divide and is prepared by the raw material of following parts by weight：5 parts of folium isatidis, 10 parts of Poria cocos, 5 parts of Radix Ophiopogonis, 15 parts of pinellia, 10 parts of tendril-leaved fritillary bulb,
10 parts of Schisandra chinensis, 5 parts of radix bupleuri, 5 parts of Radix Astragali.
3. as described in claim 1 treatment pulmonary infection of AIDS oral solution, which is characterized in that the drug effect of the oral solution at
Divide and is prepared by the raw material of following parts by weight：10 parts of folium isatidis, 15 parts of Poria cocos, 10 parts of Radix Ophiopogonis, 20 parts of pinellia, tendril-leaved fritillary bulb 15
Part, 15 parts of Schisandra chinensis, 10 parts of radix bupleuri, 10 parts of Radix Astragali.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410769091.5A CN104474256B (en) | 2014-12-12 | 2014-12-12 | A kind of oral solution for treating pulmonary infection of AIDS |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410769091.5A CN104474256B (en) | 2014-12-12 | 2014-12-12 | A kind of oral solution for treating pulmonary infection of AIDS |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN104474256A CN104474256A (en) | 2015-04-01 |
| CN104474256B true CN104474256B (en) | 2018-11-02 |
Family
ID=52748957
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410769091.5A Expired - Fee Related CN104474256B (en) | 2014-12-12 | 2014-12-12 | A kind of oral solution for treating pulmonary infection of AIDS |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104474256B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104825770B (en) * | 2015-05-12 | 2018-05-08 | 河南中医药大学 | A kind of Chinese medicine for treating pulmonary infection of AIDS |
| CN114984143A (en) * | 2022-07-12 | 2022-09-02 | 湖南省幸福大点名实业集团有限公司 | Lung-tonifying medicinal liquor and preparation method thereof |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1947745A (en) * | 2005-10-14 | 2007-04-18 | 上海凯宝药业有限公司 | Application of traditional Chinese medicine-Tanreqing injection for treating pulmonary infection of AIDS |
| CN101700321A (en) * | 2009-11-19 | 2010-05-05 | 南通艾奇康药业科技有限公司 | Chinese herbal composition for curing HIV and preparation method thereof |
| CN103784842A (en) * | 2013-06-01 | 2014-05-14 | 吕汉 | Traditional Chinese medicine preparation for assisting to treat aids (Acquired Immune Deficiency Syndrome) |
-
2014
- 2014-12-12 CN CN201410769091.5A patent/CN104474256B/en not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1947745A (en) * | 2005-10-14 | 2007-04-18 | 上海凯宝药业有限公司 | Application of traditional Chinese medicine-Tanreqing injection for treating pulmonary infection of AIDS |
| CN101700321A (en) * | 2009-11-19 | 2010-05-05 | 南通艾奇康药业科技有限公司 | Chinese herbal composition for curing HIV and preparation method thereof |
| CN103784842A (en) * | 2013-06-01 | 2014-05-14 | 吕汉 | Traditional Chinese medicine preparation for assisting to treat aids (Acquired Immune Deficiency Syndrome) |
Non-Patent Citations (2)
| Title |
|---|
| "咳嗽治法探析";郑彩霞;《中医药临床杂志》;20051231;566-568 * |
| "艾滋病咳嗽的中西医研究概况";刁喆园 等;《中华中医药学刊》;20091231;744-747 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN104474256A (en) | 2015-04-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105168759A (en) | Traditional Chinese medicine for health maintenance, prevention and treatment of respiratory system diseases | |
| CN103735673B (en) | Traditional Chinese medicine preparation for treating infantile pneumonia and preparation method thereof | |
| CN103977314A (en) | Medicinal composition for treating respiratory diseases as well as preparation method and application of medicinal composition | |
| CN104474256B (en) | A kind of oral solution for treating pulmonary infection of AIDS | |
| CN104324125A (en) | Traditional Chinese medicine composition for treating chronic pharyngitis and preparation method thereof | |
| CN102091307B (en) | Traditional Chinese medicine composition for treating cold | |
| CN103211970A (en) | Traditional Chinese medicine composition for treatment of wind-heat cough | |
| CN103142733B (en) | Chinese medicine composition for treating upper respiratory infection | |
| CN102552807A (en) | Chinese medicine for curing air temperature type flue and preparation method and application thereof | |
| CN102600280B (en) | Traditional Chinese medical composition for treatment of pediatric cough | |
| CN102698102A (en) | Traditional Chinese medicament for treating chronic laryngitis | |
| CN103585451A (en) | Traditional Chinese medicine for treating children allergic rhinitis | |
| CN103623369B (en) | A kind of Chinese medicinal formulae for the treatment of tonsillitis, chronic pharyngitis | |
| CN103536673B (en) | Topical powder with strong enhanced immunity for removing food retention, bringing down fever and relieving cough and asthma, and application thereof | |
| CN103251925B (en) | Traditional Chinese medicine pill for treating diphtheria | |
| CN101181509B (en) | Chinese medicine prescription orally taken for curing pulmonary emphysema | |
| CN101317989B (en) | Pure traditional Chinese medicine medicament composition for treating white plague | |
| CN105250746A (en) | Heat clearing and toxin removing oral liquid and preparation method thereof | |
| CN104958530A (en) | Traditional Chinese medicinal composition for treating infantile pneumonia | |
| CN103599497B (en) | A kind of Chinese medicine composition for the treatment of hepatitis B | |
| CN109646649A (en) | A kind of Chinese drugs agentia for treating palpitaition flu | |
| CN109331114A (en) | A kind of Chinese medicine for treating rhinitis | |
| CN106138536A (en) | One treats phthisical Chinese medicine | |
| CN108524651A (en) | A kind of Chinese medicine preparation for treating tracheitis | |
| CN108939019A (en) | A kind of Chinese drugs agentia for treating palpitaition flu |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20181102 Termination date: 20211212 |